Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Kalinin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bulletin of Experimental Biology and Medicine|June 19, 2023
KDM5 Family Demethylase Inhibitor KDOAM-25 Reduces Entry of SARS-CoV-2 Pseudotyped Viral Particles into CellsE N Knyazev, R S Kalinin, V A Abrikosova, et al.
Acta Naturae|August 18, 2018
Molecular Approaches to Safe and Controlled Engineered T-cell TherapyR S Kalinin, A V Petukhov, V D Knorre, et al.
Bulletin of Experimental Biology and Medicine|July 14, 2018
Directed Change in TNFα Specificity to Create DR5 AntagonistsV M Ukrainskaya, T V Bobik, A Argentova-Stevens, et al.
Frontiers in Molecular Biosciences|November 1, 2021
Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished SurvivalR S Kalinin, V M Ukrainskaya, S P Chumakov, et al.
Doklady. Biochemistry and Biophysics|January 18, 2023
Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward MalignancyR S Kalinin, V O Shipunova, Y P Rubtsov, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bulletin of Experimental Biology and Medicine|June 19, 2023
KDM5 Family Demethylase Inhibitor KDOAM-25 Reduces Entry of SARS-CoV-2 Pseudotyped Viral Particles into CellsE N Knyazev, R S Kalinin, V A Abrikosova, et al.
Acta Naturae|August 18, 2018
Molecular Approaches to Safe and Controlled Engineered T-cell TherapyR S Kalinin, A V Petukhov, V D Knorre, et al.
Bulletin of Experimental Biology and Medicine|July 14, 2018
Directed Change in TNFα Specificity to Create DR5 AntagonistsV M Ukrainskaya, T V Bobik, A Argentova-Stevens, et al.
Frontiers in Molecular Biosciences|November 1, 2021
Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished SurvivalR S Kalinin, V M Ukrainskaya, S P Chumakov, et al.
Doklady. Biochemistry and Biophysics|January 18, 2023
Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward MalignancyR S Kalinin, V O Shipunova, Y P Rubtsov, et al.
Pageof 1